Literature DB >> 21198735

Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet).

Daisuke Ito1, Timothy D O'Brien, Jaime F Modiano.   

Abstract

BACKGROUND: Cytoplasmic fragments derived from fragile neoplastic lymphocytes are common in samples of lymph nodes collected from dogs with lymphoma. These cytoplasmic fragments interfere with accurate gating of target cells and quantification protocols used for flow cytometry because of their variable size and expression of lymphoid cell surface antigens on their membranes.
OBJECTIVE: The aim of this study was to develop a method to efficiently exclude cytoplasmic fragments from flow cytometric analysis of canine lymph nodes in which lymphoma was present.
METHODS: Single-cell suspensions of neoplastic cells were prepared from biopsy samples and fine-needle aspirates of lymph nodes from 23 dogs with lymphoma. Suspensions were stained using a violet laser-excitable (405 nm) membrane-permeable DNA-binding fluorescent dye (DyeCycle Violet [DCV]), incubated with antibodies against CD3, CD5, CD21, CD22, and CD45, and then stained with 7-amino-actinomycin D (7-AAD), an argon-excitable (488 nm) membrane-impermeable DNA-binding fluorescent dye. Multiparameter flow cytometry was used for analysis based on selective uptake and laser-activated fluorescence of these dyes.
RESULTS: Cytoplasmic fragments, which were DCV-negative and CD45-positive, and dead cells, which were positive for 7-AAD, were efficiently separated from neoplastic cells.
CONCLUSION: Staining with DCV is a useful method to improve flow cytometric gating methods and quantitative analyses of lymph node samples from dogs with lymphoma. ©2010 American Society for Veterinary Clinical Pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21198735      PMCID: PMC3065654          DOI: 10.1111/j.1939-165X.2010.00252.x

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  8 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma.

Authors:  C M Jubala; J W Wojcieszyn; V E O Valli; D M Getzy; S P Fosmire; D Coffey; D Bellgrau; J F Modiano
Journal:  Vet Pathol       Date:  2005-07       Impact factor: 2.221

3.  Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.

Authors:  Jonathan M Irish; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

4.  Side population analysis using a violet-excited cell-permeable DNA binding dye.

Authors:  William G Telford; Jolene Bradford; William Godfrey; Robert W Robey; Susan E Bates
Journal:  Stem Cells       Date:  2006-12-21       Impact factor: 6.277

5.  Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Authors:  Tomás Alvaro; Marylène Lejeune; Maria-Teresa Salvadó; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

6.  Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.

Authors:  Na-Ri Lee; Eun-Kee Song; Kyu Yun Jang; Ha Na Choi; Woo Sung Moon; Keunsang Kwon; Ju-Hyung Lee; Chang-Yeol Yim; Jae-Yong Kwak
Journal:  Leuk Lymphoma       Date:  2008-02

7.  Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms.

Authors:  S Savaşan; M Büyükavci; S Buck; Y Ravindranath
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

8.  Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.

Authors:  Dominik Pretscher; Luitpold V Distel; Gerhard G Grabenbauer; Michael Wittlinger; Maike Buettner; Gerald Niedobitek
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

  8 in total
  2 in total

1.  A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.

Authors:  D Ito; M M Endicott; C M Jubala; K M Helm; R C Burnett; B D Husbands; A Borgatti; M S Henson; K E Burgess; J S Bell; W C Kisseberth; V E Valli; G R Cutter; A C Avery; K A Hahn; T D O'Brien; J F Modiano
Journal:  J Vet Intern Med       Date:  2011 Jul-Aug       Impact factor: 3.333

2.  Stimulation with Concanavalin-A Induces IL-17 Production by Canine Peripheral T Cells.

Authors:  Michelle G Ritt; Beth A Lindborg; Timothy D O'Brien; Joseph Bisignano; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.